Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury

Shi-Hao Ni,Jin-Dong Xu,Shu-Ning Sun,Yue Li,Zheng Zhou,Huan Li,Xin Liu,Jian-Ping Deng,Yu-Sheng Huang,Zi-Xin Chen,Wen-Jun Feng,Jia-Jia Wang,Shao-Xiang Xian,Zhong-Qi Yang,Sheng Wang,Ling-Jun Wang,Lu Lu
DOI: https://doi.org/10.1093/cvr/cvab193
IF: 13.081
2021-06-08
Cardiovascular Research
Abstract:Abstract Aims The goal of our study was to investigate the heterogeneity of cardiac macrophages (CMφs) in mice with transverse aortic constriction (TAC) via single-cell sequencing and identify a subset of macrophages associated with heart injury. Methods and results We selected all CMφs from CD45+ cells using single-cell mRNA sequencing data. Through dimension reduction, clustering, and enrichment analyses, CD72hi CMφs were identified as a subset of pro-inflammatory macrophages. The pseudo-time trajectory and ChIP-Seq analyses identified Rel as the key transcription factor that induces CD72hi CMφ differentiation. Rel KD and Rel−/− bone marrow chimaera mice subjected to TAC showed features of mitigated cardiac injury, including decreased levels of cytokines and ROS, which prohibited cardiomyocyte death. The transfer of adoptive Rel-overexpressing monocytes and CD72hi CMφ injection directly aggravated heart injury in the TAC model. The CD72hi macrophages also exerted pro-inflammatory and cardiac injury effects associated with myocardial infarction. In humans, patients with heart failure exhibit increased CD72hi CMφ levels following dilated cardiomyopathy and ischaemic cardiomyopathy. Conclusion Bone marrow-derived, Rel-mediated CD72hi macrophages play a pro-inflammatory role, induce cardiac injury and, thus, may serve as a therapeutic target for multiple cardiovascular diseases.
cardiac & cardiovascular systems
What problem does this paper attempt to address?